Cochlear Limited

ASX:COH Stock Report

Market Cap: AU$17.1b

Cochlear Past Earnings Performance

Past criteria checks 2/6

Cochlear has been growing earnings at an average annual rate of 31.5%, while the Medical Equipment industry saw earnings growing at 18.4% annually. Revenues have been growing at an average rate of 12.2% per year. Cochlear's return on equity is 19.8%, and it has net margins of 16%.

Key information

31.5%

Earnings growth rate

30.8%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate12.2%
Return on equity19.8%
Net Margin16.0%
Next Earnings Update15 Aug 2025

Recent past performance updates

Recent updates

Unpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) Shares

Apr 05
Unpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) Shares

Cochlear (ASX:COH) Will Pay A Larger Dividend Than Last Year At A$2.15

Mar 06
Cochlear (ASX:COH) Will Pay A Larger Dividend Than Last Year At A$2.15

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Feb 23
Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
author-image

New Cochlear Implant Launch And Market Expansion Will Strengthen Future Prospects

Feb 23 Focus on adult and senior markets in developed countries could drive revenue and net margin growth through increased sales volume.

Is Cochlear Limited (ASX:COH) Worth AU$310 Based On Its Intrinsic Value?

Feb 08
Is Cochlear Limited (ASX:COH) Worth AU$310 Based On Its Intrinsic Value?

Earnings Not Telling The Story For Cochlear Limited (ASX:COH)

Dec 20
Earnings Not Telling The Story For Cochlear Limited (ASX:COH)

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Nov 19
Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 04
Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18
We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19
Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16
Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Aug 01
Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Jun 08
Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Revenue & Expenses Breakdown

How Cochlear makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ASX:COH Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Dec 242,309371936294
30 Sep 242,272364917286
30 Jun 242,236357898277
31 Mar 242,193354886273
31 Dec 232,149350874270
30 Sep 232,043326842257
30 Jun 231,936301810245
31 Mar 231,824281768230
31 Dec 221,713261725215
30 Sep 221,681275691213
30 Jun 221,648289658211
31 Mar 221,612273628208
31 Dec 211,575257597205
30 Sep 211,536291579200
30 Jun 211,498324560195
31 Mar 211,40382549187
31 Dec 201,308-160537180
30 Sep 201,314-199550182
30 Jun 201,321-238564185
31 Mar 201,40034569188
31 Dec 191,479306574190
30 Sep 191,453291560187
30 Jun 191,427277546184
31 Mar 191,422270535180
31 Dec 181,418264525175
30 Sep 181,391255510172
30 Jun 181,364246494168
31 Mar 181,329234475164
31 Dec 171,294223456160
30 Sep 171,274223444156
30 Jun 171,254224432152
31 Mar 171,218215426149
31 Dec 161,182206420146
30 Sep 161,156198412146
30 Jun 161,131189403145
31 Mar 161,088179383142
31 Dec 151,045168362138
30 Sep 15986157341133
30 Jun 15926146320128
31 Mar 15899145308126
31 Dec 14872144296124
30 Sep 14839119288126
30 Jun 1480594279128

Quality Earnings: COH has high quality earnings.

Growing Profit Margin: COH's current net profit margins (16%) are lower than last year (16.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: COH's earnings have grown significantly by 31.5% per year over the past 5 years.

Accelerating Growth: COH's earnings growth over the past year (5.8%) is below its 5-year average (31.5% per year).

Earnings vs Industry: COH earnings growth over the past year (5.8%) did not outperform the Medical Equipment industry 19.6%.

Return on Equity

High ROE: COH's Return on Equity (19.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/15 13:30
End of Day Share Price 2025/04/15 00:00
Earnings2024/12/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cochlear Limited is covered by 29 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterANZ Equities Pty Limited
Saul HadassinBarrenjoey Markets Pty Limited
Stuart RobertsBell Potter